In patients with suspected venous thromboembolism (VTE) (i.e., deep venous thrombosis [DVT] 
D e s i g n
Blinded comparison of the results of the latex D-dimer test (MDA D-Dimer, Organon Teknika Corporation, Durham, NC, USA) with objective testing done at presentation and during follow-up (3 mo).
S e t t i n g
4 tertiary-care university medical centers in Ontario, Canada.
P a t i e n t s
595 patients (60% women) with suspected VTE (317 with suspected DVT and 278 with suspected PE). D e s c r i p t i o n o f t e s t s a n d d i a g n o s t i c s t a n d a r d
All patients had a clinical examination and were classified into low-, intermediate-, or high-probability categories according to a previously validated model. Patients with suspected DVT or PE were tested objectively by using 1 of several validated algorithms.
All patients without objective evidence of DVT or PE at presentation were followed for 3 months. Those with symptoms of VTE during follow-up were tested objectively to confirm or exclude the diagnosis. M a i n r e s u l t s
The prevalence of VTE was 19%. 21% of patients with suspected DVT were DVTpositive, and 17% of patients with suspected PE were PE-positive. Positive D-dimer test results had poor likelihood ratios (1.3 to 2.2); thus, a positive test result was not helpful for ruling in VTE. Negative test results had low likelihood ratios (0.0 to 0.25), making them useful for ruling out VTE, especially in patients with low or intermediate pretest probabilities (Table) . 
C o n c l u s i o n

C o m m e n t a r y
Diagnosis of VTE is still a challenge in current clinical practice. The hazards of this difficult diagnosis include underdiagnosing VTE with possibly fatal consequences, prescribing anticoagulants to a patient who does not have VTE, and ordering a series of expensive tests that are not useful. The clinical goal is to use a rapid, accessible, and inexpensive test that confidently rules out VTE. The study by Bates and colleagues shows that a negative quantitative D-dimer test alone can rule out VTE in some patients, especially those with a low clinical probability of the disease. Although previously validated (1, 2), one could argue that this method of clinical stratification into low, moderate, and high probability of VTE is still somewhat subjective, and a repeat study could give different results in other clinical practices. Despite this restriction, the value of the test in the mixed group of patients with low or moderate pretest probability of VTE remains clinically useful (sensitivity 97%, specificity 46%, +LR 1.8, and −LR 0.07). Although mentioned, the economic consequences of the 
